Please use this identifier to cite or link to this item: 10.4172/1758-4272.1000171
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKajuna, Irina-
dc.contributor.authorStanevica, Valda-
dc.contributor.authorMikažāne, Helēna-
dc.date.accessioned2022-11-21T12:50:02Z-
dc.date.available2022-11-21T12:50:02Z-
dc.date.issued2018-
dc.identifier.citationKajuna , I , Stanevica , V & Mikažāne , H 2018 , ' Antiphospholipid antibodies and single nucleotide polymorphisms in patients with venous ulcer in the population of Latvia ' , International Journal of Clinical Rheumatology , vol. 13 , no. 2 , pp. 108-113 . https://doi.org/10.4172/1758-4272.1000171-
dc.identifier.issn1758-4272-
dc.identifier.otherMendeley: 75c59712-5142-3751-9cf0-2ccef767ce1d-
dc.identifier.urihttps://dspace.rsu.lv/jspui/handle/123456789/9793-
dc.description.abstractBackground: Chronic venous insufficiency (CVI) may lead to leg ulceration (CVI stage C6) (Nicolaides A.N. et al., 2000). Some authors published that genetic risk factors are observed more frequently in patients with CVI stage C6. Also, an increased level of anticardiolipin antibodies (ACA) is observed in patients with CVI stage C6. CVI stage C6 more frequently develops in CVI stage C3 patients with positive antiphospholipid antibodies (APA) when compared to CVI stage C3 patients without APA. Objective: To identify the association of single nucleotide polymorphisms (SNPs) of genes F5 (rs6025), F2 (rs1799963), SELE (rs5361), SERPINC1 (rs2227589), FGG (rs20066865), CYP4V2 (rs13146272), F11 (rs2289252), GP6 (rs1613662) and APA antibodies with CVI stage in the population of Latvia. Methods: The study group consisted of 188 CVI patients. APA was detected in 89 CVI patients. The diagnostics of CVI was based on clinical and duplex ultrasound data (Philips Sparq, 2012). APA was detected using ELISA assay (according to the manufacturer’s protocol (Demeditec Diagnostics GmbH, Germany)). Statistical analysis was performed using Plink 1.06. Software and Fisher exact tests. Results: Polymorphism of gene F11 (rs2289252) showed an association with CVI stage C6 (OR=1.81 (p=0.024). A statistically significant elevation of APA was observed in patients with CVI stage C6 when compared to patients with CVI stage C3 (p=0.05). Conclusions: The polymorphism of gene F11 (rs2289252) and positive APA showed an association with CVI stage C6.en
dc.format.extent153477-
dc.language.isoeng-
dc.relation.ispartofInternational Journal of Clinical Rheumatology-
dc.rightsinfo:eu-repo/semantics/openAccess-
dc.subjectsingle nucleotide polymorphisms-
dc.subjecttrophic ulcers-
dc.subjectchronic venous insufficiency-
dc.subjectvenous ulcer-
dc.subjectantiphospholipid antibodies-
dc.subjectanticardiolipin-
dc.subjectantibodies-
dc.subjectantiphospholipid-
dc.subjectsyndrome-
dc.subject3.2 Clinical medicine-
dc.subject1.4. Reviewed scientific article published in Latvia or abroad in a scientific journal with an editorial board (including university editions)-
dc.titleAntiphospholipid antibodies and single nucleotide polymorphisms in patients with venous ulcer in the population of Latviaen
dc.type/dk/atira/pure/researchoutput/researchoutputtypes/contributiontojournal/article-
dc.identifier.doi10.4172/1758-4272.1000171-
dc.contributor.institutionRīga Stradiņš University-
dc.identifier.urlhttps://www.mendeley.com/catalogue/75c59712-5142-3751-9cf0-2ccef767ce1d/-
dc.description.statusPeer reviewed-
Appears in Collections:Research outputs from Pure / Zinātniskās darbības rezultāti no ZDIS Pure



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.